Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin J Churchyard

Showing results (51-60 of 135) with videos related to

Pageof 14
Sort By:
AIDS (London, England)|May 25, 2010
Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South AfricaChristopher J Hoffmann, Katherine L Fielding, Salome Charalambous, et al.
BMC Medicine|March 24, 2016
The timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort studySabine M Hermans, Alison D Grant, Violet Chihota, et al.
AIDS (London, England)|June 4, 2009
HIV suppression with stavudine 30 mg versus 40 mg in adults over 60 kg on antiretroviral therapy in South AfricaChristopher J Hoffmann, Salome Charalambous, Katherine L Fielding, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|October 30, 2016
Verbal autopsy-assigned causes of death among adults being investigated for TB in South AfricaNoriah Maraba, Aaron S Karat, Kerrigan McCarthy, et al.
AIDS (London, England)|November 17, 2010
Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programmeSalome Charalambous, Alison D Grant, Craig Innes, et al.
Open Forum Infectious Diseases|April 22, 2021
Performance of GeneXpert MTB/RIF for Diagnosing Tuberculosis Among Symptomatic Household Contacts of Index Patients in South AfricaKavindhran Velen, Laura J Podewils, N Sarita Shah, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 5, 2017
Strategies to Accelerate HIV Care and Antiretroviral Therapy Initiation After HIV Diagnosis: A Randomized TrialChristopher J Hoffmann, Tonderai Mabuto, Sibuse Ginindza, et al.
BMC Public Health|July 24, 2010
Contrasting predictors of poor antiretroviral therapy outcomes in two South African HIV programmes: a cohort studyMison Dahab, Salome Charalambous, Alan S Karstaedt, et al.
Vaccine|June 1, 2025
Sample size efficiency of restricting participation in tuberculosis vaccine trials to interferon-gamma release assay-positive participantsFrank Cobelens, Puck T Pelzer, Gavin J Churchyard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 1, 2015
Brief Report: The Effect of Antiretroviral Therapy and CD4 Count on Markers of Infectiousness in HIV-Associated TuberculosisClare L van Halsema, Katherine L Fielding, Violet N Chihota, et al.
Pageof 14

Showing results (51-60 of 135) with videos related to

Sort By:
Pageof 14
AIDS (London, England)|May 25, 2010
Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South AfricaChristopher J Hoffmann, Katherine L Fielding, Salome Charalambous, et al.
BMC Medicine|March 24, 2016
The timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort studySabine M Hermans, Alison D Grant, Violet Chihota, et al.
AIDS (London, England)|June 4, 2009
HIV suppression with stavudine 30 mg versus 40 mg in adults over 60 kg on antiretroviral therapy in South AfricaChristopher J Hoffmann, Salome Charalambous, Katherine L Fielding, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|October 30, 2016
Verbal autopsy-assigned causes of death among adults being investigated for TB in South AfricaNoriah Maraba, Aaron S Karat, Kerrigan McCarthy, et al.
AIDS (London, England)|November 17, 2010
Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programmeSalome Charalambous, Alison D Grant, Craig Innes, et al.
Open Forum Infectious Diseases|April 22, 2021
Performance of GeneXpert MTB/RIF for Diagnosing Tuberculosis Among Symptomatic Household Contacts of Index Patients in South AfricaKavindhran Velen, Laura J Podewils, N Sarita Shah, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 5, 2017
Strategies to Accelerate HIV Care and Antiretroviral Therapy Initiation After HIV Diagnosis: A Randomized TrialChristopher J Hoffmann, Tonderai Mabuto, Sibuse Ginindza, et al.
BMC Public Health|July 24, 2010
Contrasting predictors of poor antiretroviral therapy outcomes in two South African HIV programmes: a cohort studyMison Dahab, Salome Charalambous, Alan S Karstaedt, et al.
Vaccine|June 1, 2025
Sample size efficiency of restricting participation in tuberculosis vaccine trials to interferon-gamma release assay-positive participantsFrank Cobelens, Puck T Pelzer, Gavin J Churchyard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 1, 2015
Brief Report: The Effect of Antiretroviral Therapy and CD4 Count on Markers of Infectiousness in HIV-Associated TuberculosisClare L van Halsema, Katherine L Fielding, Violet N Chihota, et al.
Pageof 14